News

News

Troponin test could be used to assess future risk of heart disease

Research by Professor Nick Mills, Centre for Cardiovascular Science, University of Edinburgh and the University of Glasgow suggest that the troponin test curently used to help diognose a heart attack could be used to identify people who will benefit from statins, and could monitor whether patients are responding to treatment.

Kidney Research UK visit CVS

Dr Morag Mansley shows KRUK fundraisers her research

Fundraisers and shop staff from Kidney Research UK joined with renal patients, researchers and clinicians for a special day of presentations and lab visits to highlight renal research in CVS and the University of Edinburgh.

CVS research on maternal obesity published

Research findings from work carried out on maternal obesity in the CVS have been published in the Lancet

IgM antibodies provide vital protection early during infection

Paper published in Nature Communications

BHF Bake Sale

Here at the Centre for Cardiovascular Science a new British Heart Foundation Fundraising Team has recently been set up, consisting of Masters and PhD students. As part of the CVS coffee morning the team thought what better way to get some donations for BHF than to set up their first Fundraising event- a BHF bake sale!

The bake sale saw some fantastic and scrumptious bakes being kindly baked by the team and others around the Centre. The cakes were fast to sell and a very generous £134.21 (and 5 Namibian cents!) was donated to the British Heart Foundation.

New therapy aids bid to beat organ failure caused by pancreatitis

Xray structure

A team from the University’s Medical Research Council Centre for Inflammation Research and the University/BHF Centre for Cardiovascular Science worked with scientists from GlaxoSmithKline to identify a chemical compound that blocks KMO. In carefully controlled studies using mice and rats, they found that this approach calms inflammation in acute pancreatitis and protects against organ failure caused by the condition. The research is the product of a Discovery Partnership with Academia (DPAc) collaboration between the University of Edinburgh and GlaxoSmithKline (GSK).